Source: Annual Congress 2009 - Infections, immunity and inflammation
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
P. Holt, L. Subrata, J. Bizzintino, A. Bosco, K. McKenna, J. Goldblatt, P. Sly, I. Laing, P. Lesouef (Perth, Australia). Interactions between antiviral and atopic inflammatory pathways sustain asthma exacerbations in children. Eur Respir J 2009; 34: Suppl. 53, 1605

Member's Comments

No comment yet.

Related content which might interest you: Role of respiratory infection in exacerbations of atopic asthma Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests Year: 2008 Macrolides targeting multiple immune pathways in asthma and COPD Source: Virtual Congress 2021 – Pharmacology of lung immune responses: which pathways to target! Year: 2021 Omalizumab therapy reduces asthma exacerbations in children with severe allergic (IgE-mediated) asthma irrespective of lung function at baseline Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges Year: 2009 Variants of allergic response in children with bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 162s Year: 2004 IL-33 in patients with severe uncontrolled allergic asthma Source: International Congress 2017 – "Alarming" immunological patterns in asthma Year: 2017 The prevention of virus-induced exacerbation of bronchial asthma in children Source: Annual Congress 2012 - Treating childhood asthma Year: 2012 The role of viral infections in asthma and asthma exacerbations Source: Annual Congress 2010 - ERS/[italic]Lancet[/italic] Asthma Year: 2010 Heterogeneous response of airway eosinophilia to biologics in severe asthma patients Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021 Immunotherapy prevents the development of asthma in subjects with allergic rhinitis Source: Eur Respir J 2001; 18: Suppl. 33, 482s Year: 2001 Role of viral pathogens in infectious exacerbations of bronchial asthma in adults Source: Annual Congress 2012 - Asthma: assessment and treatment Year: 2012 Viruses as a critical trigger in the development of acute exacerbations of asthma Source: International Congress 2019 – Mechanisms underlying acute exacerbation of respiratory disease Year: 2019 Viruses as a critical trigger in the development of acute exacerbations of asthma Source: ERS Lung Science Conference 2019 Year: 2019 Effects of omalizumab on markers of eosinophilic inflammation in patients with severe allergic asthma Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Associations between inflammatory endotypes and phenotypes of obesity at young patients with bronchial asthma Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities Year: 2020 Determination of value the biomarkers of an inflammation at atopic asthma exacerbation caused by respiratory infection Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges Year: 2010 Continuing allergic inflammation determines asthma chronicity in children Source: Eur Respir J 2006; 28: Suppl. 50, 850s Year: 2006 Dupilumab improves lung function and reduces severe exacerbations in uncontrolled persistent asthma patients with ongoing allergic rhinitis Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017 Dupilumab efficacy in children with uncontrolled, moderate-to-severe asthma with and without an allergic phenotype Source: Virtual Congress 2021 – Advances in childhood asthma: biologics, biomarkers and infections Year: 2021 Different immunoregulatory background in atopic and nonatopic asthma in children Source: Eur Respir J 2001; 18: Suppl. 33, 369s Year: 2001 Airway inflammation in non-eosinophilic atopic asthma: comparisons with eosinophilic atopic asthma and COPD Source: Eur Respir J 2005; 26: Suppl. 49, 733s Year: 2005